ScRNA-seq has also revealed heterogeneous tumor and immune cell populations in the TME of early-stage lung adenocarcinomas harboring EGFR mutations, among which myeloid cells, T cells, tumor-associated macrophages (TAMs), and dendritic cells (DCs) are prominent. The gene discussed is EGFR; the disease is neoplasm.